HealthSouth Corporation (NYSE:HLS) has been given an average recommendation of “Hold” by the twelve ratings firms that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $48.80.

A number of brokerages have recently issued reports on HLS. Piper Jaffray Companies reissued a “hold” rating and set a $50.00 target price on shares of HealthSouth Corporation in a research note on Thursday, August 3rd. Mizuho increased their target price on HealthSouth Corporation from $44.00 to $47.00 and gave the stock a “neutral” rating in a research note on Monday, July 10th. Zacks Investment Research downgraded HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Tuesday, August 15th. Royal Bank Of Canada reissued a “buy” rating and set a $53.00 target price on shares of HealthSouth Corporation in a research note on Wednesday, July 5th. Finally, ValuEngine raised HealthSouth Corporation from a “hold” rating to a “buy” rating in a research note on Friday, July 7th.

COPYRIGHT VIOLATION NOTICE: “HealthSouth Corporation (HLS) Given Consensus Rating of “Hold” by Analysts” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/28/healthsouth-corporation-hls-given-consensus-rating-of-hold-by-analysts.html.

In related news, CEO Mark J. Tarr sold 22,625 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $43.00, for a total value of $972,875.00. Following the sale, the chief executive officer now owns 283,134 shares in the company, valued at approximately $12,174,762. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

Several large investors have recently added to or reduced their stakes in HLS. UBS Asset Management Americas Inc. boosted its stake in HealthSouth Corporation by 4.3% in the fourth quarter. UBS Asset Management Americas Inc. now owns 72,087 shares of the company’s stock worth $2,973,000 after buying an additional 2,959 shares in the last quarter. Bank of Montreal Can boosted its stake in HealthSouth Corporation by 0.7% in the first quarter. Bank of Montreal Can now owns 300,489 shares of the company’s stock worth $12,864,000 after buying an additional 2,066 shares in the last quarter. Fox Run Management L.L.C. purchased a new stake in HealthSouth Corporation during the first quarter worth $231,000. Louisiana State Employees Retirement System boosted its stake in HealthSouth Corporation by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 22,500 shares of the company’s stock worth $963,000 after buying an additional 300 shares in the last quarter. Finally, State of Alaska Department of Revenue purchased a new stake in HealthSouth Corporation during the first quarter worth $235,000. Institutional investors and hedge funds own 93.10% of the company’s stock.

HealthSouth Corporation (NYSE:HLS) traded down 0.09% during midday trading on Wednesday, hitting $44.35. The company’s stock had a trading volume of 435,465 shares. The company has a market cap of $4.38 billion, a price-to-earnings ratio of 16.16 and a beta of 0.61. The company’s 50-day moving average is $44.43 and its 200 day moving average is $44.52. HealthSouth Corporation has a one year low of $36.97 and a one year high of $49.71.

HealthSouth Corporation (NYSE:HLS) last issued its earnings results on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.68 by $0.03. The business had revenue of $981.30 million during the quarter, compared to the consensus estimate of $976.46 million. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.69 EPS. On average, analysts predict that HealthSouth Corporation will post $2.71 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Monday, October 2nd will be issued a $0.25 dividend. The ex-dividend date is Friday, September 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.25%. This is a boost from HealthSouth Corporation’s previous quarterly dividend of $0.24. HealthSouth Corporation’s dividend payout ratio is currently 35.29%.

About HealthSouth Corporation

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Analyst Recommendations for HealthSouth Corporation (NYSE:HLS)

Receive News & Stock Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related stocks with our FREE daily email newsletter.